Prostate cancer in a male with Holt-Oram syndrome: first clinical association of the TBX5 mutation.
AffiliationDepartment of Radiation Oncology, North Coast Cancer Institute, Coffs Harbour, NSW 2450, Australia.
Local subject classificationHOLT-ORAM SYNDROME
MetadataShow full item record
CitationAherne NJ, Rangaswamy G, Thirion P. Prostate cancer in a male with Holt-Oram syndrome: first clinical association of the TBX5 mutation. Case Rep Urol. 2013, 2013:405343 Case Rep Urol
PublisherHindawi Publishing Corp.
JournalCase reports in urology
AbstractHolt-Oram syndrome is an autosomal dominant disorder which is caused by mutations of TBX5 and is characterised by cardiac and skeletal abnormalities. TBX5 is part of the T-box gene family and is thought to upregulate tumour cell proliferation and metastasis when mutated. We report the first clinical case of prostate cancer in an individual with Holt Oram syndrome.
- Clinical and molecular characterisation of Holt-Oram syndrome focusing on cardiac manifestations.
- Authors: Jhang WK, Lee BH, Kim GH, Lee JO, Yoo HW
- Issue date: 2015 Aug
- Novel TBX5 mutations in patients with Holt-Oram syndrome.
- Authors: Debeer P, Race V, Gewillig M, Devriendt K, Frijns JP
- Issue date: 2007 Sep
- Novel TBX5 duplication in a Japanese family with Holt-Oram syndrome.
- Authors: Kimura M, Kikuchi A, Ichinoi N, Kure S
- Issue date: 2015 Jan
- Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome.
- Authors: Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, Grayzel D, Kroumpouzou E, Traill TA, Leblanc-Straceski J, Renault B, Kucherlapati R, Seidman JG, Seidman CE
- Issue date: 1997 Jan
- KLF13 is a genetic modifier of the Holt-Oram syndrome gene TBX5.
- Authors: Darwich R, Li W, Yamak A, Komati H, Andelfinger G, Sun K, Nemer M
- Issue date: 2017 Mar 1